|
Post by JEvans on Jun 27, 2020 19:49:58 GMT -5
It's recent run to just under $2.50 was short lived, but expected. Every time it has a small run, it falls flat even faster. Something to do with $1.60 warrants, future pipeline news, analyst comments. Always something theoretical brings it up, but hard reality brings it down.
This run felt/feels a little different. Management has been working harder to get real Afrezza's medical benefit facts out to the people who prescribe it and opening doors for better partnering opportunities not only with world wide Afrezza sales, but with their Technosphere technology and analyst are taking notice. Maybe the run isn't done? I hope not!!!!
But, until share price moves above $6.00 (preferably $9.00) where the price should be at minimum, this board will always have negative comments. It's the way it should be, after all management has failed to deliver a superior product...............period
|
|
|
Post by morfu on Jun 28, 2020 19:28:33 GMT -5
It's recent run to just under $2.50 was short lived, but expected. Every time it has a small run, it falls flat even faster. Something to do with $1.60 warrants, future pipeline news, analyst comments. Always something theoretical brings it up, but hard reality brings it down. This run felt/feels a little different. Management has been working harder to get real Afrezza's medical benefit facts out to the people who prescribe it and opening doors for better partnering opportunities not only with world wide Afrezza sales, but with their Technosphere technology and analyst are taking notice. Maybe the run isn't done? I hope not!!!! But, until share price moves above $6.00 (preferably $9.00) where the price should be at minimum, this board will always have negative comments. It's the way it should be, after all management has failed to deliver a superior product...............period >> until share price moves above $6.00 (preferably $9.00)
I will bite (and maybe regret it), but what is your basis and time horizon for these values?
|
|
|
Post by JEvans on Jun 28, 2020 22:42:53 GMT -5
It's recent run to just under $2.50 was short lived, but expected. Every time it has a small run, it falls flat even faster. Something to do with $1.60 warrants, future pipeline news, analyst comments. Always something theoretical brings it up, but hard reality brings it down. This run felt/feels a little different. Management has been working harder to get real Afrezza's medical benefit facts out to the people who prescribe it and opening doors for better partnering opportunities not only with world wide Afrezza sales, but with their Technosphere technology and analyst are taking notice. Maybe the run isn't done? I hope not!!!! But, until share price moves above $6.00 (preferably $9.00) where the price should be at minimum, this board will always have negative comments. It's the way it should be, after all management has failed to deliver a superior product...............period >> until share price moves above $6.00 (preferably $9.00)
I will bite (and maybe regret it), but what is your basis and time horizon for these values?
My basis is my gut. I was wrong when I bought originally but management has screwed us. I think there on the right path now. I think Afrezza and Technosphere technology are hands down the best on the market for years to come and I feel share prices will reflect this very soon
|
|
|
Post by morfu on Jun 29, 2020 8:55:57 GMT -5
>> until share price moves above $6.00 (preferably $9.00)
I will bite (and maybe regret it), but what is your basis and time horizon for these values?
My basis is my gut. I was wrong when I bought originally but management has screwed us. I think there on the right path now. I think Afrezza and Technosphere technology are hands down the best on the market for years to come and I feel share prices will reflect this very soon ah, while I am admire your honesty here, I was hoping for an explanation how you and professional analists come up with these price targets.. "Just the numbers" would not even support the current share price as Mannkind is loosing money and will be doing so for a while. How do price in a couple of potential blockbuster drugs in the near and distant future? But whatever the dollar number is you come up with, it is even less useful if it does not come with a time horizon.. 9$ per share in 50years from now would make this a very crappy investient!
|
|
|
Post by wmdhunt on Jun 29, 2020 10:23:13 GMT -5
Without data, you are just another person with an opinion...
|
|
|
Post by sportsrancho on Jun 30, 2020 17:50:47 GMT -5
|
|
|
Post by mytakeonit on Jun 30, 2020 18:17:32 GMT -5
I use to subscribe to Forbes ... until I found that I was losing $$$ following their advice. But, if you want a subscription ... I'm sure you can get over 95% off discount coupons all over the place. But, that's mytakeonit
|
|
|
Post by sportsrancho on Jun 30, 2020 18:19:18 GMT -5
I use to subscribe to Forbes ... until I found that I was losing $$$ following their advice. But, if you want a subscription ... I'm sure you can get over 95% off discount coupons all over the place. But, that's mytakeonit The CEO I used to work for was on the cover once..some Fortune 500 article.
|
|
|
Post by letitride on Jun 30, 2020 18:23:38 GMT -5
Great article in a credible publication. Glad to see we got the attention of Forbes. Hopefully the attention of a whole new group of legitimate investors as well. Lets Go!
|
|
|
Post by mytakeonit on Jun 30, 2020 18:37:58 GMT -5
The article is "top stocks to short as consumer confidence exceeds expectations". So if investors look at the "exceeds expectations" part and buy in ... then that is the proper way to view it.
I assume that this article is here because the short numbers for MNKD has been dropping.
But, that's mytakeonit
|
|
|
Post by cretin11 on Jun 30, 2020 18:56:34 GMT -5
Great article in a credible publication. Glad to see we got the attention of Forbes. Hopefully the attention of a whole new group of legitimate investors as well. Lets Go! Great article?
|
|
|
Post by prcgorman2 on Jun 30, 2020 19:19:03 GMT -5
Forbes magazine, the published paper journal tends to be very good. My opinion of Forbes, the on-line version is perhaps only marginally better than Motley Fool or Seeking Alpha. (I so want to say Motley Stool and Seeking Alpo.) The last time I looked at the on-line version of Forbes it seemed it indulged in using the same kinds of voluntary pseudo-journalism contributions as MF and SA from wannabe investor analysts who either have never been an analyst or who couldn’t make it as an analyst. I haven’t looked at the link, but I assume it’s the latter version, click bait, and not worth my time.
|
|
|
Post by pat on Jun 30, 2020 19:25:58 GMT -5
This reads like an auto generated mess. I suspect the “AI” is just reacting to the run up and down. As I understand it they just feed market datasets through rudimentary algorithm ‘filters’ to produce this stuff.
|
|
|
Post by porkini on Jun 30, 2020 19:27:46 GMT -5
Forbes magazine, the published paper journal tends to be very good. My opinion of Forbes, the on-line version is perhaps only marginally better than Motley Fool or Seeking Alpha. (I so want to say Motley Stool and Seeking Alpo.) The last time I looked at the on-line version of Forbes it seemed it indulged in using the same kinds of voluntary pseudo-journalism contributions as MF and SA from wannabe investor analysts who either have never been an analyst or who couldn’t make it as an analyst. I haven’t looked at the link, but I assume it’s the latter version, click bait, and not worth my time. Yes, just keep your eyes closed, like a roller coaster, you will be fine! PS - Don't forget to scream once in a while!
|
|
|
Post by nylefty on Jun 30, 2020 19:41:48 GMT -5
Great article in a credible publication. Glad to see we got the attention of Forbes. Hopefully the attention of a whole new group of legitimate investors as well. Lets Go! Great article? It's actually an advertorial, not an unbiased article.
Q.ai - Investing Reimagined Contributor Q.ai uses advanced quantitative techniques and artificial intelligence to generate investment recommendations.
In tiny type after the "article" is the word ADVERTISEMENT.
|
|